These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 29307592)

  • 1. Complex noradrenergic dysfunction in Alzheimer's disease: Low norepinephrine input is not always to blame.
    Gannon M; Wang Q
    Brain Res; 2019 Jan; 1702():12-16. PubMed ID: 29307592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer's disease.
    Ponnusamy R; McNerney MW; Moghadam S; Salehi A
    Brain Res; 2019 Jan; 1702():3-11. PubMed ID: 29102776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heightened Hippocampal β-Adrenergic Receptor Function Drives Synaptic Potentiation and Supports Learning and Memory in the TgF344-AD Rat Model during Prodromal Alzheimer's Disease.
    Goodman AM; Langner BM; Jackson N; Alex C; McMahon LL
    J Neurosci; 2021 Jun; 41(26):5747-5761. PubMed ID: 33952633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease.
    Kelly SC; He B; Perez SE; Ginsberg SD; Mufson EJ; Counts SE
    Acta Neuropathol Commun; 2017 Jan; 5(1):8. PubMed ID: 28109312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine.
    Heneka MT; Nadrigny F; Regen T; Martinez-Hernandez A; Dumitrescu-Ozimek L; Terwel D; Jardanhazi-Kurutz D; Walter J; Kirchhoff F; Hanisch UK; Kummer MP
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6058-63. PubMed ID: 20231476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of neuroinflammation, microglial activation, and degeneration of the locus coeruleus-norepinephrine system in APP/PS1 and aging mice.
    Cao S; Fisher DW; Rodriguez G; Yu T; Dong H
    J Neuroinflammation; 2021 Jan; 18(1):10. PubMed ID: 33407625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer's Disease.
    Bekdash RA
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early loss of locus coeruleus innervation promotes cognitive and neuropathological changes before amyloid plaque deposition in a transgenic rat model of Alzheimer's disease.
    Flores-Aguilar L; Hall H; Orciani C; Foret MK; Kovecses O; Ducatenzeiler A; Cuello AC
    Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12835. PubMed ID: 35822518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease.
    Kalinin S; Gavrilyuk V; Polak PE; Vasser R; Zhao J; Heneka MT; Feinstein DL
    Neurobiol Aging; 2007 Aug; 28(8):1206-14. PubMed ID: 16837104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microstructural integrity of the locus coeruleus and its tracts reflect noradrenergic degeneration in Alzheimer's disease and Parkinson's disease.
    Lin CP; Frigerio I; Bol JGJM; Bouwman MMA; Wesseling AJ; Dahl MJ; Rozemuller AJM; van der Werf YD; Pouwels PJW; van de Berg WDJ; Jonkman LE
    Transl Neurodegener; 2024 Feb; 13(1):9. PubMed ID: 38336865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noradrenergic System in Down Syndrome and Alzheimer's Disease A Target for Therapy.
    Phillips C; Fahimi A; Das D; Mojabi FS; Ponnusamy R; Salehi A
    Curr Alzheimer Res; 2016; 13(1):68-83. PubMed ID: 26391048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The locus coeruleus neuroprotective drug vindeburnol normalizes behavior in the 5xFAD transgenic mouse model of Alzheimer's disease.
    Braun D; Feinstein DL
    Brain Res; 2019 Jan; 1702():29-37. PubMed ID: 29274883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease.
    Rorabaugh JM; Chalermpalanupap T; Botz-Zapp CA; Fu VM; Lembeck NA; Cohen RM; Weinshenker D
    Brain; 2017 Nov; 140(11):3023-3038. PubMed ID: 29053824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional consequences of locus coeruleus degeneration in Alzheimer's disease.
    Weinshenker D
    Curr Alzheimer Res; 2008 Jun; 5(3):342-5. PubMed ID: 18537547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies.
    Slater C; Wang Q
    Clin Transl Med; 2021 Apr; 11(4):e397. PubMed ID: 33931975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies.
    Szot P; White SS; Greenup JL; Leverenz JB; Peskind ER; Raskind MA
    J Neurosci; 2006 Jan; 26(2):467-78. PubMed ID: 16407544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system.
    Feinstein DL; Kalinin S; Braun D
    J Neurochem; 2016 Oct; 139 Suppl 2():154-178. PubMed ID: 26968403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice.
    Heneka MT; Ramanathan M; Jacobs AH; Dumitrescu-Ozimek L; Bilkei-Gorzo A; Debeir T; Sastre M; Galldiks N; Zimmer A; Hoehn M; Heiss WD; Klockgether T; Staufenbiel M
    J Neurosci; 2006 Feb; 26(5):1343-54. PubMed ID: 16452658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Noradrenergic Brain Nuclei in the Regulation of Carotid Artery Blood Flow: Pharmacological Evidence from Anesthetized Pigs with Alpha-2 Adrenergic Receptor Modulator Drugs.
    Wirth KJ
    J Alzheimers Dis; 2018; 66(1):407-419. PubMed ID: 30248055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Widespread Reduced Density of Noradrenergic Locus Coeruleus Axons in the App Knock-In Mouse Model of Amyloid-β Amyloidosis.
    Sakakibara Y; Hirota Y; Ibaraki K; Takei K; Chikamatsu S; Tsubokawa Y; Saito T; Saido TC; Sekiya M; Iijima KM
    J Alzheimers Dis; 2021; 82(4):1513-1530. PubMed ID: 34180416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.